Mozo PAL, Beltrán REE, Mateus OCC, Parody MA, Avendaño ECL

Language: Spanish
References: 15
Page: 1-14
PDF size: 874.74 Kb.

ABSTRACT

Introduction: Intensive physical therapy in orphan diseases is a method for the treatment of patients with different neurological disorders, especially neuromuscular and skeletal muscle dysfunction as a consequence of metabolic crisis suffered due to a neurodegenerative disease which has as a characteristic that the patients present a particular smell in the urine, similar to the maple syrup used as food.
Objective: To describe the results obtained through the use of intensive physical therapy in patients with orphan diseases.
Case presentation: Nine years old boy with secondary sequelae of the above mentioned neurodegenerative disease. The initial evaluation was made with the index of motor function called GMFM 88-66 used before and after each intervention. The treatment involves the development of a program based in the intensive physical therapy in 4 sessions during 4 weeks and 4 hours each day, without stops and with a total of 80 hours per each intervention.
Conclusions: Intensive physical therapy in orphan diseases provides significant changes in comparison with the traditional physiotherapy. It combines different techniques focused in the physiologic base of the exercises; in the case of neurodegenerative diseases, it increased the chances of improvement in the sequelaes of the motor level, and it improved the gross motor function in the boy. In general terms, there is evidence of changes in the evolution of the patient and impact in the skeletal muscle system, in the neuromuscular dysfunction and improvement in the clinical and life quality. This technique can be used in other children with motor disruptions secondary to orphan or rare diseases.

REFERENCES

1. Alagesan J, Shetty A. Effect of modified suit therapy in spastic diplegic cerebral palsy-a single blinded randomized controlled trial. J Health Allied Sci. 2011 [acceso 04/06/2019];9(4):14. Disponible en: http://www.cogprints.org/7257/1/2010-4-14.pdf

2. Oliveira L. Curso teórico y práctico básico. Protocolo Pediasuit. 2019. Florida, EE. UU [acceso 04/06/2019]. Disponible en: http://www.pediasuit-esp.com/sobre-pediasuit 3. Anaya A. PEDIASUIT para niños con diversas patologías. 2015. Diario Los Tiempos. 3 de octubre de 2015 [acceso 12/07/2019]. Disponible en: https://www.lostiempos.com/oh/tendencias/20151003/pediasuit-ninos-diversas-patologias

3. Karadağ E, Giray E. The clinical aspects and effectiveness of suit therapies for cerebral palsy: A systematic review. Turkish J Physic Med Rehabilitat. 2019;5(1):93-110. doi: 10.5606/tftrd.2019.3431.

4. Lee K, Park J, Lee H, Nam K, Park T, Kim H. Efficacy of intensive neuro developmental treatment for children with developmental delay, with or without cerebral palsy. Ann Rehabilitat Med. 2017;41(1):90-6. doi: 10.5535/arm.2017.41.1.90.

5. Strauss K, Carson V, Soltys K, Young M, Bowser L. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes. Mol Genet Metabol. 2020;129(3):193-206. doi: https://doi.org/10.1016/j.ymgme.2020.01.006. 7. Marchantt H, Lippi, Q, Villanueva C, Selamé, G, Puchi A. Enfermedad de orina con olor a jarabe de arce: reporte de dos casos.Rev ANACEM. 2016;10(1):30-4.

6. Abiri M, Saei H, Eghbali M, Karamzadeh R, Shirzadeh T, Sharifi Z. Maple syrup urine disease mutation spectrum in a cohort of 40 consanguineous patients and insilico analysis of novel mutations. Metabolic Brain Dis. 2019;34(4):1-12. doi: 10.1007/s11011-019-00435-y.

7. Menkes J, Hurst P, Craig J. A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics J. 1954;14(5):462. 10. Lanza A, Montalvan E. Enfermedad de la orina de jarabe de arce: trastornos metabólicos y limitaciones en honduras. Rev Méd Honduras. 2017;85(1)(2):35- 9.

8. Meneses J. Protocolo de manejo nutricional para niños con enfermedad de orina con olor a jarabe de arce y fenilcetonuria en el Hospital Universitario San Ignacio [tesis] Bogotá, Colombia: Pontificia Universidad Javeriana; 2015.

9. Vallejo M, Valencia D. Estudio técnico de métodos TheraSuit, PediaSuit, PenguinSuit y Adelitsuit para pacientes con parálisis cerebral en el marco del procedimiento técnico científico y participativo de exclusiones. Reporte N° 10. Colombia: Universidad Nacional, Instituto de Evaluación Tecnológica en Salud; 2018. [acceso 27/04/2020]. Disponible en: https://www.mivoxpopuli.minsalud.gov.co/InscripcionParticipacionCiudadana/DOCUMENTOS/a/22_Therasuit.pdf

10. 1Wilbarger J, Wilbarger P. Wilbarger approach to treating sensory defensiveness and clinical application of the sensory diet. Sections in alternative and complementary programs for intervention. In: Bundy AC, Murray EA, Lane S, editors. Sensory integration: Theory and Practice, 2nd ed. Philadelphia: F.A. Davis; 2002

11. Marek SM, Cramer JT, Fincher AL, Massey LL, Dangelmaier SM, Purkayastha S, et al. Acute effects of static and propioceptive neuromuscular facilitation stretching on muscle stregth and power output. J Athl Train. 2005;40(2):94-103. PMID: 15970955.

12. Duchateau J, Semmier JG, Enoka RM. Training adaptations in the behavior of human motor units. J Appl Physiol. 2006;101(6):1766-75. doi: 10.1152/Japplphysiol.00543,2006.

13. Budtinger L, Bombarda A. Método Pediasuit ™ en el tratamiento de la parálisis cerebral: informes de casos. Fis Senectus Uno Chapecó. 2018;6(1) 4-12.

14. Licona T, Banegas L. Enfermedad de Orina Olor a Jarabe de Arce: presentación de caso clínico. Acta Pediátr Hondureña. 2015;6(1):423-9 [acceso 20/07/2019]. Disponible en: http://www.bvs.hn/APH/pdf/APHVol6/pdf/APHVol6-1-2015-9.pdf

15. Zeltner N, Baumgartne M, Bondarenko A, Ensenauer R, Karall D, Kölker S. Development and psychometric evaluation of the MetabQoL 1.0: a quality of life questionnaire for Paediatric patients with intoxication-type inborn errors of metabolism. Informes JIMD. 2017;37: 27-35. doi: https://doi.org/10.1007/8904_2017_11